Furthermore, investigations have demonstrated promising outcomes of anti-CD200 therapy in the treatment of gliomas in dogs and also hold potential as a treatment modality for CLL in dogs [55]. The gene discussed is CD200; the disease is B-cell chronic lymphocytic leukemia.